https://www.alojapan.com/1293640/samsung-bioepis-partners-with-nipro-to-commercialize-biosimilars-in-japan-world-business-outlook/ Samsung Bioepis Partners with NIPRO to Commercialize Biosimilars in Japan » World Business Outlook #agreement #biosimilar #Biosimilars #business #Collaborating #footprint #healthcare #innovation #investment #Japan #JapanNews #license #medicines #news #partnership #samsung #SB17 #technology #ustekinumab #WBO #WorldBusinessOutlook Samsung Bioepis Co., Ltd., on June 8th, announced that the company has entered into a license, development and comm…
#ustekinumab
💊💉 #ustekinumab SmPC for STELARA 90 mg solution for injection in pre-filled syringe has been updated with changes to sections 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; Revised: 13/11/2024. 🌐 https://www.medicines.org.uk/emc/product/7638/smpc Change log: https://www.medicines.org.uk/emc/product/7638/smpc/history
💊💉 #ustekinumab SmPC for STELARA 45 mg solution for injection in pre-filled syringe has been updated with changes to sections 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 6.3 Shelf life; 6.4 Special precautions for storage; Revised: 13/11/2024. 🌐 https://www.medicines.org.uk/emc/product/7639/smpc Change log: https://www.medicines.org.uk/emc/product/7639/smpc/history
💊💉 #ustekinumab SmPC for STELARA 130 mg concentrate for solution for infusion has been updated with changes to sections 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; Revised: 13/11/2024. 🌐 https://www.medicines.org.uk/emc/product/4412/smpc Change log: https://www.medicines.org.uk/emc/product/4412/smpc/history
💊💉 #ustekinumab SmPC for STELARA 90 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 6.3 Shelf life; 6.4 Special precautions for storage; Revised: 13/11/2024. 🌐 https://www.medicines.org.uk/emc/product/15190/smpc Change log: https://www.medicines.org.uk/emc/product/15190/smpc/history
💊💉 #ustekinumab SmPC for STELARA 45 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 6.3 Shelf life; 6.4 Special precautions for storage; Revised: 13/11/2024. 🌐 https://www.medicines.org.uk/emc/product/15189/smpc Change log: https://www.medicines.org.uk/emc/product/15189/smpc/history
💊💉 #ustekinumab SmPC for STELARA 45 mg solution for injection has been updated with changes to sections 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.6 Fertility, pregnancy; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 6.4 Special precautions for storage; Revised: 13/11/2024. 🌐 https://www.medicines.org.uk/emc/product/4413/smpc Change log: https://www.medicines.org.uk/emc/product/4413/smpc/history
I'm now keeping an eye on: The SmPC for STELARA 45 mg solution for injection (vials)
🏭Janssen-Cilag Ltd
💊💉 #ustekinumab.
I will let you know if it changes.
💊💉 #ustekinumab
SmPC for STELARA 90 mg solution for injection in pre-filled syringe has been updated with changes to sections 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 6.3 Shelf life; 6.5 Nature and contents of container; 10. Date of revision of the text on 18/01/2024.
🌐 https://www.medicines.org.uk/emc/product/7638/smpc
Change log: https://www.medicines.org.uk/emc/product/7638/smpc/history
💊💉 #ustekinumab
SmPC for STELARA 45 mg solution for injection in pre-filled syringe has been updated with changes to sections 5.1 Pharmacodynamic properties; 5.2 Pharmacokinetic properties; 6.3 Shelf life; 6.5 Nature and contents of container; 6.6 Special precautions for disposal and other handling; 10. Date of revision of the text on 18/01/2024.
🌐 https://www.medicines.org.uk/emc/product/7639/smpc
Change log: https://www.medicines.org.uk/emc/product/7639/smpc/history
💊💉 #ustekinumab SmPC for STELARA 130 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology; 4.4 Special warnings; 4.5 Interaction with other medicinal products; 4.8 Undesirable effects; 5.1 Pharmacodynamic; Revised: 18/01/2024. 🌐 https://www.medicines.org.uk/emc/product/4412/smpc Change log: https://www.medicines.org.uk/emc/product/4412/smpc/history
I'm now keeping an eye on: The SmPC for Stelara 90 mg solution for injection in pre-filled pen
🏭Janssen-Cilag Ltd
💊💉 #ustekinumab.
I will let you know if it changes.
I'm now keeping an eye on: The SmPC for Stelara 45 mg solution for injection in pre-filled pen
🏭Janssen-Cilag Ltd
💊💉 #ustekinumab.
I will let you know if it changes.
I'm glad to share our last letter about relationship between #ustekinumab levels and #crohnsdisease evolution
Thanks Fran Lao, MJosé Fobelo y demás. El mérito es vuestro.
@AGSSurSevilla
Client Info
Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst